Translational Approaches for Precision Medicine in Sarcopenia: Mechanisms, Clinical Relevance, and Therapeutic Perspectives

Skeletal muscle is a crucial component of the mammalian body, supporting movement, metabolism, and overall physical function. Aging leads to progressive muscle deterioration, resulting in sarcopenia, a multifactorial condition characterized by declining muscle mass, strength, and physical performance. The development of sarcopenia is influenced by intrinsic factors, including genetic predisposition, cellular senescence, mitochondrial dysfunction, and altered intercellular signaling, as well as extrinsic factors such as nutrition, physical activity, and environmental exposures. Recent advances in translational research have enabled the investigation of these mechanisms through in vitro skeletal muscle models, including myoblast cultures, senescence-induced systems, and three-dimensional muscle constructs, which facilitate the identification of molecular targets and therapeutic candidates. Among emerging biomarkers, exosomal cargos released by aged skeletal muscle have gained significant attention due to their roles in mediating communication between muscle and distant tissues. These extracellular vesicles carry lipids, proteins, and non-coding RNAs that may serve as diagnostic and prognostic biomarkers and as potential therapeutic agents. Integrating exosome-based technologies with precision medicine approaches offers opportunities for patient stratification and individualized treatment strategies. Although clinical applications remain limited, ongoing studies are evaluating pharmacological interventions, nutritional strategies, exercise programs, and exosome-based therapies for the prevention and treatment of sarcopenia. This review discusses the translational progression from in vitro models to clinical applications, highlighting how exosome biology and precision medicine approaches may contribute to innovative diagnostics and personalized therapeutics for sarcopenia.

Authors

Institutions

Publication Details

Journal
Journal of Food and Drug Analysis
Published
2026-11-16
DOI
https://doi.org/10.38212/2224-6614.3617
Primary Topic
Nutrition and Health in Aging
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Translational Approaches for Precision Medicine in Sarcopenia: Mechanisms, Clinical Relevance, and Therapeutic Perspectives

Frank Luh, Wen‐Hsuan Hou, Yifan Chen, Yun Yen et al.
Journal of Food and Drug Analysis
Nutrition and Health in Aging
article

Translational Approaches for Precision Medicine in Sarcopenia: Mechanisms, Clinical Relevance, and Therapeutic Perspectives

Frank Luh, Wen‐Hsuan Hou, Yifan Chen, Yun Yen, Yu-Ru Guo
article en

Abstract

Skeletal muscle is a crucial component of the mammalian body, supporting movement, metabolism, and overall physical function. Aging leads to progressive muscle deterioration, resulting in sarcopenia, a multifactorial condition characterized by declining muscle mass, strength, and physical performance. The development of sarcopenia is influenced by intrinsic factors, including genetic predisposition, cellular senescence, mitochondrial dysfunction, and altered intercellular signaling, as well as extrinsic factors such as nutrition, physical activity, and environmental exposures. Recent advances in translational research have enabled the investigation of these mechanisms through in vitro skeletal muscle models, including myoblast cultures, senescence-induced systems, and three-dimensional muscle constructs, which facilitate the identification of molecular targets and therapeutic candidates. Among emerging biomarkers, exosomal cargos released by aged skeletal muscle have gained significant attention due to their roles in mediating communication between muscle and distant tissues. These extracellular vesicles carry lipids, proteins, and non-coding RNAs that may serve as diagnostic and prognostic biomarkers and as potential therapeutic agents. Integrating exosome-based technologies with precision medicine approaches offers opportunities for patient stratification and individualized treatment strategies. Although clinical applications remain limited, ongoing studies are evaluating pharmacological interventions, nutritional strategies, exercise programs, and exosome-based therapies for the prevention and treatment of sarcopenia. This review discusses the translational progression from in vitro models to clinical applications, highlighting how exosome biology and precision medicine approaches may contribute to innovative diagnostics and personalized therapeutics for sarcopenia.

Journal of Food and Drug AnalysisVol. 34(4)
Taipei Medical University Hospital (TW), Taipei Medical University (TW)
Nutrition and Health in Aging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon